Plant-Based Formula
    Clinically Studied Botanicals
    Vegetarian Capsule
    Plant-Based Formula
    Clinically Studied Botanicals
    Vegetarian Capsule
    Plant-Based Formula
    Clinically Studied Botanicals
    Vegetarian Capsule
    Plant-Based Formula
    Clinically Studied Botanicals
    Vegetarian Capsule

    Ingredient Deep Dive

    AprèsFlex® Boswellia serrata

    A patented, high-absorption Boswellia extract standardized for AKBA. The full breakdown: what it is, how it works, and what the research shows.

    Back to The Science

    100 mg per capsule

    What is Boswellia serrata?

    Also known as Indian frankincense

    Boswellia serrata is a tree native to India whose resin has been used in traditional practice for centuries. The active compounds are a family of triterpenoid acids called boswellic acids, with AKBA (acetyl-11-keto-β-boswellic acid) being the most studied for joint comfort.

    Modern Boswellia extracts vary widely in AKBA content and how well they're absorbed. That's why standardization and the specific extract form matter.

    Why AprèsFlex® specifically

    AprèsFlex® (also marketed as Aflapin®) is a patented Boswellia extract that combines a Boswellia serrata extract enriched with AKBA and a non-volatile oil component of the same resin, which enhances absorption.

    AprèsFlex® is a Boswellia serrata extract standardized to 20% AKBA, studied in published human trials at 100 mg per day. The 100 mg dose in Bendwell matches the dose used in the published clinical trials.

    How AprèsFlex® works in the body

    AKBA is the boswellic acid most studied for joint comfort. AprèsFlex® delivers it in a highly absorbable form, studied for its role in supporting the body's healthy response to the everyday physical stress that active joints take on.*

    What the research shows

    • A randomized, double-blind study showed AprèsFlex® at 100 mg/day improved joint comfort and function scores in as few as 5 days.*
    • Systematic reviews of Boswellia serrata extracts report improvements in joint comfort and physical function compared to placebo.
    • AprèsFlex® pairs an AKBA-enriched Boswellia extract with a non-volatile oil component of the same resin, formulated for enhanced absorption of AKBA.
    • Standardized to deliver enhanced levels of AKBA, the most studied boswellic acid for joint comfort.

    Common questions

    What is AprèsFlex®?

    AprèsFlex® (also known as Aflapin®) is a patented Boswellia serrata extract standardized to deliver enhanced levels of AKBA, the most clinically relevant boswellic acid. It pairs that extract with a non-volatile oil component of the same resin, which enhances absorption.

    How is it different from regular Boswellia?

    Standard Boswellia extracts vary widely in AKBA content and bioavailability. AprèsFlex® uses a non-volatile oil component of the resin to enhance solubility and absorption, which improves how much of the active compound reaches the bloodstream.

    How long does AprèsFlex® take to work?

    Published clinical trials have reported measurable improvements in joint comfort and function in as few as 5 days, with continued benefits studied at 30 and 90 days of consistent use.

    How much AprèsFlex® is in Bendwell?

    Each capsule contains 100 mg of AprèsFlex® — the dose used in its published human clinical trials.

    Outcomes were observed in randomized, double-blind, placebo-controlled trials of AprèsFlex® (Boswellia serrata). They describe the studied ingredient, not a guaranteed outcome for any individual; individual results vary.

    * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    AprèsFlex® is a registered trademark of PLT Health Solutions-Laila Nutraceuticals LLC.

    KINEXA™ is a trademark of PLT Health Solutions-Laila Nutraceuticals LLC.

    © 2026 BENDWELL

    No charge today. No automatic billing.